Eric Thervet

Summary

Country: France

Publications

  1. ncbi Histologic recurrence of Henoch-Schonlein Purpura nephropathy after renal transplantation on routine allograft biopsy
    Eric Thervet
    Universite Paris Descartes, Paris, France
    Transplantation 92:907-12. 2011
  2. ncbi Combined posttransplant prophylactic IVIg/anti-CD 20/plasmapheresis in kidney recipients with preformed donor-specific antibodies: a pilot study
    Alexandre Loupy
    INSERM, U970, Paris Cardiovascular Research Center PARCC, Paris, France
    Transplantation 89:1403-10. 2010
  3. ncbi Effects of cinacalcet in renal transplant patients with hyperparathyroidism
    Marie Courbebaisse
    Service d Explorations Fonctionnelles, Hôpital Necker Enfants Malades Assistance Publique Hôpitaux de Paris, Paris, France
    Am J Nephrol 35:341-8. 2012
  4. ncbi [Involvement of endoplasmic reticulum stress in solid organ transplantation]
    Nicolas Pallet
    INSERM U775, Centre Universitaire des Saints Peres, Paris, France
    Med Sci (Paris) 26:397-403. 2010
  5. ncbi Incidence of infectious complications in highly sensitized renal transplant recipients treated by rituximab: a case-controlled study
    Anne Scemla
    Department of Renal Transplantation, Assistance Publique Hopitaux de Paris, Hopital Necker, Paris, France
    Transplantation 90:1180-4. 2010
  6. ncbi Urinary procollagen III aminoterminal propeptide (PIIINP): a fibrotest for the nephrologist
    Balsam El Ghoul
    Department of Nephrology, Universite Paris Descartes, Hopital Necker, Paris, France
    Clin J Am Soc Nephrol 5:205-10. 2010
  7. ncbi Consequences of genetic polymorphisms for sirolimus requirements after renal transplant in patients on primary sirolimus therapy
    Dany Anglicheau
    Unité INSERM UMR S490, Molecular Toxicology, Centre Universitaire des Saints Peres, Universite Rene Descartes, Paris, France
    Am J Transplant 5:595-603. 2005
  8. ncbi Cholecalciferol supplementation does not protect against renal allograft structural and functional deterioration: a retrospective study
    Marie Courbebaisse
    Service de Nephrologie, Hôpital Tenon Assistance Publique Hôpitaux de Paris et Université Paris VI, Paris, France
    Transplantation 91:207-12. 2011
  9. ncbi Antiapoptotic properties of recombinant human erythropoietin protects against tubular cyclosporine toxicity
    Nicolas Pallet
    INSERM U775 and Université Paris Descartes, Paris, France
    Pharmacol Res 61:71-5. 2010
  10. ncbi [Endoplasmic reticulum stress in kidney diseases: a question of life and death?]
    Nicolas Pallet
    INSERM U775, Centre Universitaire des Saints Peres, Universite Paris Descartes, 45, rue des Saints Pères, 75006 Paris, France
    Nephrol Ther 5:173-80. 2009

Detail Information

Publications59

  1. ncbi Histologic recurrence of Henoch-Schonlein Purpura nephropathy after renal transplantation on routine allograft biopsy
    Eric Thervet
    Universite Paris Descartes, Paris, France
    Transplantation 92:907-12. 2011
    ..However, its true incidence is unknown. The aim of this study was to investigate this recurrence incidence using routine allograft biopsies (RBs)...
  2. ncbi Combined posttransplant prophylactic IVIg/anti-CD 20/plasmapheresis in kidney recipients with preformed donor-specific antibodies: a pilot study
    Alexandre Loupy
    INSERM, U970, Paris Cardiovascular Research Center PARCC, Paris, France
    Transplantation 89:1403-10. 2010
    ....
  3. ncbi Effects of cinacalcet in renal transplant patients with hyperparathyroidism
    Marie Courbebaisse
    Service d Explorations Fonctionnelles, Hôpital Necker Enfants Malades Assistance Publique Hôpitaux de Paris, Paris, France
    Am J Nephrol 35:341-8. 2012
    ..Long-term treatment with cinacalcet may increase urinary calcium excretion and the risk of renal calcium deposits and may alter renal graft function...
  4. ncbi [Involvement of endoplasmic reticulum stress in solid organ transplantation]
    Nicolas Pallet
    INSERM U775, Centre Universitaire des Saints Peres, Paris, France
    Med Sci (Paris) 26:397-403. 2010
    ....
  5. ncbi Incidence of infectious complications in highly sensitized renal transplant recipients treated by rituximab: a case-controlled study
    Anne Scemla
    Department of Renal Transplantation, Assistance Publique Hopitaux de Paris, Hopital Necker, Paris, France
    Transplantation 90:1180-4. 2010
    ..Use of rituximab for various indications in renal transplantation is increasing. However, tolerance and complications associated with rituximab therapy remain controversial...
  6. ncbi Urinary procollagen III aminoterminal propeptide (PIIINP): a fibrotest for the nephrologist
    Balsam El Ghoul
    Department of Nephrology, Universite Paris Descartes, Hopital Necker, Paris, France
    Clin J Am Soc Nephrol 5:205-10. 2010
    ..Thus, a noninvasive alternative to KB is required. Collagen type III amino-terminal propeptide (PIIINP) is a degradation product of collagen type III, the increase of which may reflect an ongoing fibrotic process...
  7. ncbi Consequences of genetic polymorphisms for sirolimus requirements after renal transplant in patients on primary sirolimus therapy
    Dany Anglicheau
    Unité INSERM UMR S490, Molecular Toxicology, Centre Universitaire des Saints Peres, Universite Rene Descartes, Paris, France
    Am J Transplant 5:595-603. 2005
    ..In patients with SRL-based therapy, genotyping of the CYP3As genes may help to optimize the SRL management in transplant recipients...
  8. ncbi Cholecalciferol supplementation does not protect against renal allograft structural and functional deterioration: a retrospective study
    Marie Courbebaisse
    Service de Nephrologie, Hôpital Tenon Assistance Publique Hôpitaux de Paris et Université Paris VI, Paris, France
    Transplantation 91:207-12. 2011
    ..Renal models of chronic kidney injury and clinical observational studies have suggested that vitamin D analogues may protect against the epithelial-to-mesenchymal transition (EMT), interstitial inflammation, and fibrosis...
  9. ncbi Antiapoptotic properties of recombinant human erythropoietin protects against tubular cyclosporine toxicity
    Nicolas Pallet
    INSERM U775 and Université Paris Descartes, Paris, France
    Pharmacol Res 61:71-5. 2010
    ..In conclusion, we describe here a new potential target of recombinant human erythropoietin and our results provide an interesting framework for further nephroprotective therapies based on recombinant human erythropoietin...
  10. ncbi [Endoplasmic reticulum stress in kidney diseases: a question of life and death?]
    Nicolas Pallet
    INSERM U775, Centre Universitaire des Saints Peres, Universite Paris Descartes, 45, rue des Saints Pères, 75006 Paris, France
    Nephrol Ther 5:173-80. 2009
    ..The purpose of this review is to summarize the existing data concerning the role of the endoplasmic reticulum stress during kidney injury and to clarify its precise role in chronic kidney disease...
  11. ncbi Role of pharmacogenetics of immunosuppressive drugs in organ transplantation
    Eric Thervet
    Service de transplantation rénale, Hopital Necker, Paris, France
    Ther Drug Monit 30:143-50. 2008
    ....
  12. ncbi High-dosage intravenous immunoglobulin-associated macrovacuoles are associated with chronic tubulointerstitial lesion worsening in renal transplant recipients
    Guillaume Bollée
    Laboratoire d Anatomie Pathologique, Hopital Necker, APHP, and Université René Descartes, Paris, France
    Clin J Am Soc Nephrol 3:1461-8. 2008
    ..Intravenous immunoglobulins (IVIg) may induce acute renal failure associated with tubular vacuolization. Although the use of IVIg is increasing in kidney transplantation, their impact on graft histology and function remains unknown...
  13. ncbi New computerized color image analysis for the quantification of interstitial fibrosis in renal transplantation
    Vannary Meas-Yedid
    Institut Pasteur, Quantitative Image Analysis Unit, Cell Biology and Infection Department, CNRS URA 2582, Paris, France
    Transplantation 92:890-9. 2011
    ..Currently, assessed by semiquantitative analysis in the Banff classification, IF quantification is limited by pathologist's subjective interpretation...
  14. ncbi Long-term outcome of third kidney transplants
    Alexandre Loupy
    Service de Transplantation Rénale et de Soins Intensifs, Hopital Necker, and Université René Descartes, Paris, France
    Nephrol Dial Transplant 22:2693-700. 2007
    ....
  15. ncbi Endoplasmic reticulum stress: an unrecognized actor in solid organ transplantation
    Nicolas Pallet
    INSERM U775 and Université Paris Descartes, Centre Universitaire des Saints Peres, Paris, France
    Transplantation 88:605-13. 2009
    ....
  16. ncbi Impact of cytochrome p450 3A5 genetic polymorphism on tacrolimus doses and concentration-to-dose ratio in renal transplant recipients
    Eric Thervet
    INSERM UMR S490, Centre Universitaire des Saints Peres, Paris, France
    Transplantation 76:1233-5. 2003
    ..Subjects with the CYP3A5*1/*1 genotype express large amounts of CYP3A5. Heterozygotes (genotype CYP3A5*1/*3) also express the enzyme. We postulated that CYP3A5 polymorphism is associated with tacrolimus pharmacokinetic variations...
  17. ncbi Glomerular collapse associated with subtotal renal infarction in kidney transplant recipients with multiple renal arteries
    Guillaume Canaud
    Universite Paris Descartes, Paris, France
    Am J Kidney Dis 55:558-65. 2010
    ..Together, these data suggest that acute glomerular ischemia may lead to glomerular collapse in kidney transplants...
  18. ncbi Autophagy protects renal tubular cells against cyclosporine toxicity
    Nicolas Pallet
    INSERM U775, Centre Universitaire des Saints Peres, Universite Paris Descartes, Paris, France
    Autophagy 4:783-91. 2008
    ..Taken together, these results demonstrate that CsA, through ER stress induction, activates autophagy as a protection against cell death...
  19. ncbi Sirolimus therapy following early cyclosporine withdrawal in transplant patients: mechanisms of action and clinical results
    Eric Thervet
    Service de transplantation rénale, Hopital Necker, Paris, France
    Int J Nanomedicine 1:269-81. 2006
    ..Other studies are mandatory to define the population who can benefit from this maneuver. Finally, complete CsA avoidance has been already reported and is currently under clinical investigation...
  20. ncbi Clinical outcomes during the first three months posttransplant in renal allograft recipients managed by C2 monitoring of cyclosporine microemulsion
    Eric Thervet
    Service de Nephrologie et Transplantation Renale, Hopital St Louis, Paris, France
    Transplantation 76:903-8. 2003
    ..Efficacy and safety results from the first 3 months are presented here...
  21. ncbi CYP3A5 and MDR1 genetic polymorphisms and cyclosporine pharmacokinetics after renal transplantation
    Dany Anglicheau
    Unité INSERM UMR S490, Centre Universitaire des Saints Peres, Paris, France
    Clin Pharmacol Ther 75:422-33. 2004
    ..We postulated that, in renal transplant recipients, these SNPs could be associated with interindividual variations in cyclosporine pharmacokinetics...
  22. ncbi Impact of surgical procedures and complications on outcomes of third and subsequent kidney transplants
    Alexandre Loupy
    Service de transplantation rénale, Hopital Necker, Paris, France
    Transplantation 83:385-91. 2007
    ..Surgical procedures and complications have rarely been described in patients receiving a third or subsequent renal transplant...
  23. ncbi Rapamycin inhibits human renal epithelial cell proliferation: effect on cyclin D3 mRNA expression and stability
    Nicolas Pallet
    , Molecular Toxicology, , , Paris, France
    Kidney Int 67:2422-33. 2005
    ....
  24. ncbi Cytochrome P450 3A polymorphisms and immunosuppressive drugs: an update
    Dany Anglicheau
    Universite Rene Descartes, Service de Transplantation Rénale et de Soins Intensifs, Hopital Necker, APHP, 149 rue de Sevres, 75743, Cedex 15, Paris, France
    Pharmacogenomics 8:835-49. 2007
    ..It is now of utmost importance to prospectively test these initial results to improve the individualized use of these drugs...
  25. ncbi Quantification of interstitial fibrosis by image analysis on routine renal biopsy in patients receiving cyclosporine
    Aude Servais
    Department of Renal Transplantation, Universite Paris 5 Rene Descartes, Necker Hospital, Paris, France
    Transplantation 84:1595-601. 2007
    ..We performed a retrospective analysis to calculate IF on routine renal biopsies performed at 1 year posttransplant...
  26. ncbi Proteinuria >0.5 g/d, a prevalent prognostic factor for patient and graft survival in kidney transplantation
    Felix Cantarovich
    Hopital Necker, Service de Transplantation Adultes, Paris, France
    Clin Transplant 24:175-80. 2010
    ..5 g/d) or Scr (< or = or >120 micromol/L) along with the log-rank test for all comparisons were computed. Statistical significance was set with p-value < 0.05...
  27. ncbi Impact of norovirus/sapovirus-related diarrhea in renal transplant recipients hospitalized for diarrhea
    Damien Roos-Weil
    Service des Maladies Infectieuses et Tropicales, Hopital Necker Enfants Malades, AP HP, Centre d Infectiologie Necker Pasteur, Paris, France
    Transplantation 92:61-9. 2011
    ..Norovirus (NoV) and sapovirus (SaV) have been sporadically reported to cause chronic diarrhea in immunocompromised patients...
  28. ncbi The unfolded protein response regulates an angiogenic response by the kidney epithelium during ischemic stress
    Nicolas Bouvier
    INSERM U775, Centre Universitaire des Saints Peres, Paris, France
    J Biol Chem 287:14557-68. 2012
    ..In a rat model of acute ischemic stress, we show that the UPR is activated in parallel with VEGFA, bFGF, and ANG expression and independently of HIF-1α...
  29. ncbi FOXP3-enriched infiltrates associated with better outcome in renal allografts with inflamed fibrosis
    Julien Zuber
    Universite Paris Descartes, Paris, France
    Nephrol Dial Transplant 24:3847-54. 2009
    ..We hypothesized that Tregs might accumulate within the graft since enrichment of Tregs has been frequently described in chronically inflamed tissues...
  30. ncbi Effects of vitamin D supplementation on the calcium-phosphate balance in renal transplant patients
    Marie Courbebaisse
    Service d Explorations Fonctionnelles, Hopital Necker Enfants Malades, AP HP, Paris, France
    Kidney Int 75:646-51. 2009
    ..Hence, cholecalciferol treatment significantly increased serum 25-hydroxy vitamin D and decreased parathyroid hormone levels with no adverse effects in 25-hydroxy vitamin D-deficient renal transplant patients...
  31. ncbi Prospective comparison of the use of sirolimus and cyclosporine in recipients of a kidney from an expanded criteria donor
    Antoine Durrbach
    Department of Nephrology and Transplantation, Hôpital du Kremlin Bicêtre, Le Kremlin Bicetre, Paris, France
    Transplantation 85:486-90. 2008
    ..1% vs. CsA 8.3%; P=0.7 and 44.7+/-16.6 vs. 41.9+/-15.2 mL/min; P=0.54 respectively). These results do not support the use of SRL immediately after transplantation in expanded criteria donor recipients...
  32. ncbi Kidney transplant in black recipients: are African Europeans different from African Americans?
    Nicolas Pallet
    Service de transplantation rénale, Hopital Necker, Paris, France
    Am J Transplant 5:2682-7. 2005
    ..The results of renal transplantation in patients of African origin could be improved with universal immunosuppressive drug coverage...
  33. ncbi Addition of cyclophosphamide to steroids provides no benefit compared with steroids alone in treating adult patients with severe Henoch Schönlein Purpura
    Evangeline Pillebout
    Nephrology Department, Hopital Saint Louis, 1 av C Vellefaux, Paris, France
    Kidney Int 78:495-502. 2010
    ..The small population size of our study does not permit definitive conclusions; however, we suggest that treatment of adults with severe HSP by adding cyclophosphamide provides no benefit compared with steroids alone...
  34. ncbi Brief communication: case reports of ribavirin treatment for chronic hepatitis E
    Vincent Mallet
    Institut Cochin, Université Paris Descartes Unité Mixte de Recherche S1016, Paris, France
    Ann Intern Med 153:85-9. 2010
    ..There is currently no accepted treatment of chronic hepatitis E virus (HEV) infection...
  35. ncbi HNF1B-related diabetes triggered by renal transplantation
    Julien Zuber
    Service de Transplantation Rénale Adulte, Universite Paris Descartes, Paris Cedex 15, France
    Nat Rev Nephrol 5:480-4. 2009
    ..He had a history of gout, but his fasting blood glucose and glycated hemoglobin concentrations had been normal before transplantation...
  36. ncbi Response of human renal tubular cells to cyclosporine and sirolimus: a toxicogenomic study
    Nicolas Pallet
    INSERM U775, Universite Paris V, Centre Universitaire des Saints Peres, Paris, France
    Toxicol Appl Pharmacol 229:184-96. 2008
    ..Further studies are needed to evaluate if ER stress detection in tubular cells in human biopsies can predict CsA nephrotoxicity...
  37. ncbi Potential nonclassical effects of vitamin D in transplant recipients
    Marie Courbebaisse
    Service de Néphrologie et Dialyses, Hopital Tenon, AP HP, Paris, France
    Transplantation 89:131-7. 2010
    ..One may speculate that it could be a part of the explanation for the increased incidence of some complications observed after transplantation. Large intervention trials may therefore be of interest in this specific population...
  38. ncbi Pharmacokinetic interaction between corticosteroids and tacrolimus after renal transplantation
    Dany Anglicheau
    Service de Néphrologie et de transplantation rénale, Hopital Saint Louis, Paris, France
    Nephrol Dial Transplant 18:2409-14. 2003
    ..Corticosteroids induce both CYP3A and P-gp activity. This study was designed to investigate the presence of a clinically significant interaction between steroids and tacrolimus after renal transplantation...
  39. ncbi Benefit-risk assessment of ciclosporin withdrawal in renal transplant recipients
    Eric Thervet
    Service de Nephrologie et Transplantation Renale, Hopital Saint Louis, Paris, France
    Drug Saf 27:457-76. 2004
    ....
  40. ncbi Tryptophan depletion and the kinase GCN2 mediate IFN-γ-induced autophagy
    Sophie Fougeray
    INSERM U775, Paris, France
    J Immunol 189:2954-64. 2012
    ..These findings assign to IFN-γ a novel function in the regulation of autophagy, which, in turn, modulates IFN-γ-induced secretion of inflammatory cytokines...
  41. ncbi The genetics of kidney transplantation
    Nicolas Pallet
    INSERM U775, Centre Universitaire des Saints Peres, Universite Paris Descartes, 45, rue des Saints Pères, 75006 Paris, France
    Hum Genet 131:317-23. 2012
    ..Such enterprises will only be successful with the creation of international consortiums that connect partners in clinical, industrial, and academic transplant medicine...
  42. ncbi Successful renal retransplantation after post-transplant lymphoproliferative disease
    Alexandre Karras
    Nephrology and Renal Transplantation, , Paris, France
    Am J Transplant 4:1904-9. 2004
    ..In conclusion, renal retransplantation can be considered in patients with monomorphic PTLD history, without major risk of hematological recurrence...
  43. ncbi A retrospective analysis of thalidomide therapy in non-HIV-related Kaposi's sarcoma
    Laurence Fardet
    Department of Dermatology, Hospital Saint Louis, Paris, France
    Dermatology 215:202-5. 2007
    ..Thalidomide has antiangiogenic and immunomodulatory properties and has recently been used in the management of human malignancies. Several studies have suggested its interest for treating AIDS-related Kaposi's sarcoma...
  44. ncbi Practical recommendations for pharmacogenomics-based prescription: 2010 ESF-UB Conference on Pharmacogenetics and Pharmacogenomics
    Laurent Becquemont
    Univ Paris Sud, Faculty of Medicine Paris Sud, Pharmacology Department, Assistance Publique Hopitaux de Paris, Hopital Bicetre, Le Kremlin Bicetre, France
    Pharmacogenomics 12:113-24. 2011
    ..We hope that these practical recommendations will help physicians, biologists, scientists and other healthcare professionals to prescribe, perform and interpret these genetic tests...
  45. ncbi [Recent approaches of quantification of interstitial fibrosis in renal transplantation]
    Aude Servais
    Service de Nephrologie, Assistance Publique Hopitaux de Paris, Hopital Necker Enfants Malades, 149, rue de Sevres, 75015 Paris, France
    Med Sci (Paris) 25:945-50. 2009
    ..The prognostic value of quantitative image analysis might be increased by techniques addressing the dynamics of fibrosis matrix generation...
  46. ncbi [Non phosphocalcic actions of vitamin D]
    Marie Courbebaisse
    Hopital Tenon, AP HP, 4, rue de la Chine, 75020 Paris, France
    Med Sci (Paris) 26:417-21. 2010
    ..We present here the non phosphocalcic actions of vitamin D...
  47. ncbi Early conservative intervention for candida contamination of preservative fluid without allograft nephrectomy
    Guillaume Canaud
    Department of Kidney Transplantation, Necker Hospital, 149 rue de Sevres, 75015 Paris, France
    Nephrol Dial Transplant 24:1325-7. 2009
    ..Fungal contamination of kidney allograft preservative fluid can lead to renal arteritis and arterial wall rupture...
  48. ncbi Recurrence of nephrotic syndrome after transplantation in a mixed population of children and adults: course of glomerular lesions and value of the Columbia classification of histological variants of focal and segmental glomerulosclerosis (FSGS)
    Guillaume Canaud
    Department of Kidney Transplantation, Necker Hospital, 149 rue de Sevres, 75015, Paris, USA
    Nephrol Dial Transplant 25:1321-8. 2010
    ..However, the predictive value of this classification to assess the risk of recurrence after transplantation has not been addressed...
  49. ncbi [Recents advances in the pharmacology of immunosuppressive drugs used in organ transplantation]
    Eric Thervet
    Service de transplantation et de soins intensifs, Hopital Necker, 149, rue de Sevres, 75015 Paris, France
    Med Sci (Paris) 24:961-6. 2008
    ..A prospective study has been conducted to demonstrate the clinical consequences of this pharmacogenetic approach...
  50. ncbi Outcome of relapse in lupus nephritis: roles of reversal of renal fibrosis and response of inflammation to therapy
    Gary S Hill
    Hôpital Broussais and INSERM Unité 430, Hopital St Louis, and Hôpital Bichat, Paris, France
    Kidney Int 61:2176-86. 2002
    ..However, not all patients do so. This report explores the roles of response of inflammation to therapy and of glomerular scarring and interstitial fibrosis and their potential reversal to outcome of renal relapse...
  51. ncbi Pharmacogenetics in solid organ transplantation: present knowledge and future perspectives
    Dany Anglicheau
    , , Paris, France
    Transplantation 78:311-5. 2004
    ..Present challenges are to determine the genes of interest and to validate such determination prospectively in clinical practice...
  52. ncbi Hemophagocytic syndrome in renal transplant recipients: report of 17 cases and review of literature
    Alexandre Karras
    , , Paris, France
    Transplantation 77:238-43. 2004
    ..This rare disease is usually secondary to herpes viridae infections, mostly cytomegalovirus and Epstein-Barr virus in severely immunocompromised patients. Despite aggressive treatment, the prognosis remains poor...
  53. ncbi Down syndrome maternal serum screening in patients with renal disease
    Alexandra Benachi
    Department of Obstetrics and Gynecology, Hopital Necker Enfants Malades, Assistance Publique Hopitaux de Paris, Universite Paris Descartes, Paris, France
    Am J Obstet Gynecol 203:60.e1-4. 2010
    ..The objective of the study was to determine the value of maternal serum Down syndrome screening in patients affected by renal disease...
  54. ncbi c-Jun-N-Terminal Kinase Signaling Is Involved in Cyclosporine-Induced Epithelial Phenotypic Changes
    Nicolas Pallet
    Unité INSERM U775, Centre Universitaire des Saints Peres, Universite Paris Descartes, 75006 Paris, France
    J Transplant 2012:348604. 2012
    ..Our results suggest that CsA activates JNK signaling, which, in turn, may participate in the morphological alterations through the regulation of Snail-1 expression...
  55. ncbi Chronic graft dysfunction in renal transplant patients: potential role of plasminogen activator inhibitor type 1
    Anis Lahlou
    Service de Nephrologie A, Association Claude Bernard and INSERM U 489, Hopital Tenon, Paris, France
    Transplantation 73:1290-5. 2002
    ..We aimed to determine whether PAI-1 secretion in renal transplant patients is correlated with the decline in renal function after transplantation...
  56. ncbi Long-term renal allograft outcome after simultaneous kidney and pancreas transplantation
    Jean Philippe Rerolle
    , Service d'Urologie, , Paris, France
    Nephrol Dial Transplant 17:905-9. 2002
    ..This might be caused by acute rejection episodes or be due to more severe nephrotoxicity after SPK, because of higher doses of calcineurin inhibitors, or higher sensitivity to calcineurin-inhibitor nephrotoxicity...
  57. ncbi [Henoch-Shönlein purpura]
    Evangeline Pillebout
    Service de Nephrologie et Transplantation Renale, Hopital Saint Louis, Paris, France
    Nephrol Ther 5:663-75. 2009
    ..These specific treatments are still controversial and their efficacy has to be evaluated...
  58. ncbi 5% topical imiquimod tolerance in transplant recipients
    Amel Mebazaa
    Department of Dermatology, Saint Louis Hospital, Paris, France
    Dermatology 215:130-3. 2007
    ..Topical imiquimod is a new immunomodulator agent approved for genital warts, actinic keratosis (AK) or carcinoma, occurring in immunocompetent patients...
  59. ncbi Henoch-Schönlein Purpura in adults: outcome and prognostic factors
    Evangeline Pillebout
    INSERM U426, Faculte de Medecine X Bichat, Université Paris 07, Paris, France
    J Am Soc Nephrol 13:1271-8. 2002
    ..Identification of clinical and histologic prognostic factors may permit the design of appropriate therapeutic prospective studies...